Pharmaceuticals
Dr. Morepen Laboratories Ltd. operates large-scale pharmaceutical manufacturing facilities where uninterrupted energy supply is critical to production efficiency and compliance standards. The plant was previously dependent on diesel for process heating, resulting in high fuel expenditure and carbon-intensive operations.
Pune Gas implemented a structured diesel-to-LPG conversion strategy tailored to the plant’s operational load requirements. The transition delivered significant cost savings, improved combustion efficiency, and enhanced sustainability, without disrupting production.
Before (Diesel-Based Heating)
After (LPG System by Pune Gas)
Dr. Morepen Laboratories Ltd. is a leading pharmaceutical manufacturer with a strong focus on operational excellence, compliance, and cost optimisation. Energy reliability is critical to maintaining production consistency, process precision, and stringent quality standards across its facilities
The facility’s dependence on diesel created multiple operational and financial constraints:
While diesel ensured continuity, the cost-to-efficiency ratio was no longer optimal.
Pune Gas conducted a detailed technical and financial feasibility assessment before designing a customised LPG conversion plan aligned with process requirements.
The solution delivered:
Production Continuity: No disruption during or after transition
The project was executed through structured coordination between the Pune Gas technical team and the plant operations team. Design, installation, safety checks, and commissioning were completed with minimal interruption, ensuring a smooth and controlled transition.
Additionally, awareness gaps among channel partners were identified, highlighting the importance of structured LPG education in accelerating industrial energy transformation.
By transitioning from diesel to LPG, Dr. Morepen Laboratories Ltd. successfully optimised its fuel infrastructure for both cost efficiency and sustainability.
The project delivered measurable financial savings, improved operational performance, and reinforced the strategic value of cleaner energy adoption in pharmaceutical manufacturing.
